Arkolith/Insider Trading/EYEG/Form 4

Mann Brenda

VP of Research & DevelopmentEYEGATE PHARMACEUTICALS INC (EYEG) · full profile →Form 4 · filed May 5, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2021Tax withholding(F)191$4.13$78916K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-061946) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML